Lyell Immunopharma Inc (LYEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LYEL | ALT | ZVRA | ||
| Company | Lyell Immunopharma Inc | Altimmune Inc | Zevra Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 25.38 | 5.31 | 8.65 | ||
| High | 25.74 | 5.44 | 8.79 | ||
| Low | 24.86 | 5.19 | 8.52 | ||
| Latest | 25.25 | 5.24 | 8.71 | ||
| Change | -0.21 | -0.07 | +0.05 | ||
| % Change | -0.82% | -1.32% | +0.58% | ||
| Volume | 33,600 | 2,583,800 | 663,900 | ||
| 20-Day Average Volume | 44,365 | 3,311,605 | 1,322,675 | ||
| Previous Close | 25.46 | 5.31 | 8.66 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 20.16 | 4.69 | 8.89 | ||
| 20-Day Raw Stochastic | 94.93% | 86.94% | 36.05% | ||
| 20-Day Relative Strength | 67.44 | 63.97 | 44.64 | ||
| Weighted Alpha | +33.92 | +0.20 | -17.35 | ||
| Today's Opinion | 100% Buy | 48% Buy | 40% Sell | ||
| Previous Opinion | 100% Buy | 40% Buy | 56% Sell | ||
| Last Month's Opinion | 80% Buy | 80% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.21% since 11/28/25 | -0.38% since 11/28/25 | +3.32% since 11/28/25 | ||
| Low | 20.59 on 12/02/25 | 4.70 on 12/03/25 | 8.12 on 12/03/25 | ||
| High | 25.74 on 12/05/25 | 5.46 on 12/04/25 | 8.80 on 12/04/25 | ||
| 1-Month | |||||
| %Chg | +52.66% since 11/05/25 | +39.73% since 11/05/25 | -13.51% since 11/05/25 | ||
| Low | 16.00 on 11/06/25 | 3.76 on 11/06/25 | 8.01 on 11/21/25 | ||
| High | 25.74 on 12/05/25 | 5.46 on 12/04/25 | 9.95 on 11/18/25 | ||
| 3-Month | |||||
| %Chg | +107.82% since 09/05/25 | +38.62% since 09/05/25 | -2.68% since 09/05/25 | ||
| Low | 11.93 on 09/17/25 | 3.54 on 09/15/25 | 7.16 on 09/17/25 | ||
| High | 25.74 on 12/05/25 | 5.46 on 12/04/25 | 12.03 on 10/16/25 | ||
| 6-Month | |||||
| %Chg | +120.33% since 06/05/25 | -4.03% since 06/05/25 | -1.36% since 06/05/25 | ||
| Low | 8.46 on 06/27/25 | 2.90 on 06/26/25 | 7.16 on 09/17/25 | ||
| High | 25.74 on 12/05/25 | 7.73 on 06/25/25 | 13.16 on 07/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 535,755 | 546,752 | 490,356 | ||
| Shares Outstanding, K | 21,218 | 104,342 | 56,298 | ||
| Annual Sales | 60,000 | 20,000 | 23,610,000 | ||
| Annual Net Income | -342,990,000 | -95,060,000 | -105,510,000 | ||
| Last Quarter Sales | 20,000 | 10,000 | 26,060,000 | ||
| Last Quarter Net Income | -38,850,000 | -19,010,000 | -540,000 | ||
| 60-Month Beta | -0.11 | -0.03 | 1.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.13 on 11/12/25 | -0.21 on 11/06/25 | -0.01 on 11/05/25 | ||
| Latest Earnings Date | 11/13/25 | 11/06/25 | 11/05/25 | ||
| Most Recent Dividend | N/A | 2.910 on 02/06/17 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||